1 to 10 of 11 literature results

• Wnt pathway inhibitors are strongly down-regulated in pituitary tumors.

  The etiology of sporadic pituitary tumors is currently unknown. The Wnt pathways have been implicated in the pathogenesis of a variety of human tumors…

  Authors: Marianne S Elston, Anthony J Gill, John V Conaglen, Adele Clarkson, Janet M Shaw, Andrew J J Law, Raymond J Cook, Nicholas S Little, Roderick J Clifton-Bligh, Bruce G Robinson,…

  Source: Endocrinology. 2008 Mar

  View Full Text

• A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery.

  Oncogenic osteomalacia is a rare condition characterized by a low serum phosphate, reduced tubular reabsorption of phosphate and a low or inappropriat…

  Authors: Marianne S Elston, Inge J Stewart, Roderick Clifton-Bligh, John V Conaglen

  Source: Bone. 2007 Jan

  View Full Text

• Clinical and biochemical characteristics of patients with TSH-secreting pituitary adenomas from one New Zealand centre.

  Abstract Background: TSH-secreting pituitary adenomas (TSHoma) are a rare cause of thyrotoxicosis and need to be distinguished from the syndrome of re…

  Authors: Marianne S Elston, John V Conaglen

  Source: Internal medicine journal. 2009 Oct 22

  View Full Text

• An apparently sporadic paraganglioma with an SDHB gene germline mutation presenting at age 68 years.

  Paragangliomas (PGLs) are rare tumours arising from parasympathetic-associated paraganglia (particularly of the head and neck) or from sympathetic-ass…

  Authors: M S Elston, D Benn, B G Robinson, J V Conaglen

  Source: Internal medicine journal. 2006 Feb

  View Full Text

• Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.

  OBJECTIVE AND DESIGN: Genetic screening in multiple endocrine neoplasia type 2 (MEN 2) has led to specific management guidelines based on genotype-phe…

  Authors: Diana L Learoyd, Jessica Gosnell, Marianne S Elston, Tricia J Saurine, Anne-Louise Richardson, Leigh W Delbridge, John V Aglen, Bruce G Robinson

  Source: Clinical endocrinology. 2005 Dec

  View Full Text

• Thyrotoxic, hypokalaemic periodic paralysis: Polynesians, an ethnic group at risk.

  BACKGROUND: Thyrotoxic, hypokalaemic periodic paralysis (TPP) is a reversible cause of severe muscle weakness that occurs in a small minority of thyro…

  Authors: M S Elston, B J Orr-Walker, A M Dissanayake, J V Conaglen

  Source: Internal medicine journal. 2007 May

  View Full Text

• Lymphocytic hypophysitis with associated thyroiditis in a man with aseptic meningitis.

  OBJECTIVE: Lymphocytic hypophysitis (LH) is a rare chronic inflammatory disorder characterized by lymphocytic infiltration of the pituitary gland comm…

  Authors: Sarina Lim, Marianne S Elston, Michael J Swarbrick, John V Conaglen

  Source: Pituitary. 2009

  View Full Text

• Familial pituitary tumor syndromes.

  The vast majority of pituitary tumors are benign and occur sporadically; however, they can still result in significant morbidity and even premature mo…

  Authors: Marianne S Elston, Kerrie L McDonald, Roderick J Clifton-Bligh, Bruce G Robinson

  Source: Nature reviews. Endocrinology. 2009 Aug

  View Full Text

• Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas.

  CONTEXT: Loss of the cell adhesion protein E-cadherin is associated with invasion and metastasis in a number of malignancies. Recent studies have high…

  Authors: Marianne S Elston, Anthony J Gill, John V Conaglen, Adele Clarkson, Raymond J Cook, Nicholas S Little, Bruce G Robinson, Roderick J Clifton-Bligh, Kerrie L McDonald

  Source: The Journal of clinical endocrinology and metabolism. 2009 Apr

  View Full Text

• Insulinoma localization using hepatic venous sampling with selective arterial calcium stimulation: should a fixed calcium dose be used?

  Authors: Marianne S Elston, Michael J Swarbrick, John V Conaglen

  Source: Clinical endocrinology. 2005 Oct

  View Full Text